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ABSTRACT: Worldwide, stranded marine mammals and the network personnel who respond to
marine mammal mortality have provided much of the information regarding marine morbillivirus
infections. An assay to determine the amount of virus present in tissue samples would be useful to
assist in routine surveying of animal health and for monitoring large-scale die-off events. False
negatives from poor-quality samples prevent determination of the true extent of infection, while
only small amounts of tissue samples or archived RNA may be available at the time of collection for
future retrospective analysis. We developed a one-step duplex real-time reverse transcriptase-
quantitative-PCR assay (RT-qPCR) based on Taqman probe technology to quantify phocine
distemper virus (PDV) isolated from an outbreak in harbor (Phoca vitulina concolor) and gray seals
(Halichoerus grypus) along the northeast US coast in 2006. The glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH) gene was selected to assess RNA quality. This duplex assay is specific for
PDV and sensitive through a range of 100 to 109 copies ds-plasmid DNA. For the GAPDH target,
the reaction in duplex amplified 100 to 109 copies of ds-plasmid DNA and was detectable in
multiple seal species. This assay reduced the likelihood of false negative results due to degradation
of tissues and well-to-well variability while providing sensitive and specific detection of PDV,
which would be applicable in molecular epidemiologic studies and pathogen detection in field and
laboratory investigations involving a variety of seal species.
Key words: Duplex quantitative real-time reverse transcription polymerase chain reaction (RT-
qPCR), marine mammal strandings, northeast USA, phocine distemper virus, RNA quality, seal.
INTRODUCTION
In 2006 higher-than-expected mortality
in gray seals (Halichoerus grypus) and
harbor seals (Phoca vitulina concolor) in
Maine and Massachusetts, US, resulted in
the declaration of an unusual mortality
event (Matassa et al. 2008). A new North
American isolate of phocine distemper
virus (PDV USA 2006) was identified
during the event, representing the first
case of clinical disease and death in seals
associated with an isolated strain of PDV
in North America (Earle et al. 2011).
Mutations in the genome of PDV USA
2006 are important in understanding some
of the changes in pathogenicity observed
compared to the 1988 and 2002 PDV
European epizootics. Mutations in the F
and M genes of PDV USA 2006 were
found in virus isolates from brain that
were not present in isolates from lung,
liver, or blood, suggesting possible virus
persistence in the central nervous system
(Earle et al. 2011). Phocine distemper
virus USA 2006 also has a few amino acid
changes in the P, M, and F genes
compared to the 1988 European Ulster/
Netherlands strain (PDV 1988) responsi-
ble for the mass mortality of over half
of the harbor seal population in Europe
(Harkonen et al. 2006; Earle et al. 2011.
Phocine distemper virus USA 2006 is most
closely related to the 1988 strain and is
believed to have emerged independently
from 2002 European strains, allowing
multiple lineages to arise and circulate
among enzootically infected North Amer-
ican seals (Earle et al. 2011).
Most of what we know about the effects
of PDV on seal populations comes from
the successful amplification of viral RNA
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from tissue samples collected from strand-
ed animals. Determining the amount of
virus in tissues from beach cast seals
during large-scale die-offs offers several
challenges. Tissue degradation in the field
and adequate cold storage of samples are
common limiting factors (Lipscomb et al.
1996; Wilson et al. 2010). False negatives
resulting from poor-quality samples may
prevent detecting the true extent of
infection. Given these limitations, there
is a need for a specific and quality-
controlled test that will reliably detect
PDV in field-collected tissue samples.
We developed a one-step duplex reverse
transcriptase-quantitative-PCR assay (RT-
qPCR) assay based on Taqman probe
technology to quantify the relative expression
of PDV USA 2006 and to assess RNA quality
by amplification of the glyceraldehyde-3-
phosphate-dehydrogenase (GAPDH) gene.
The PDV H gene was targeted for its
importance in determining host-virus spec-
ificity, tropism, and cytopathogenicity (Von
Messling et al. 2004, 2006; Ohishi et al.
2008). The GAPDH gene was selected to
allow detection of host RNA in a wide
variety of seal species. The quantitative
duplex RT-qPCR was highly sensitive for
both targets and allowed for the detection
of false negative samples due to degrada-
tion of tissue. This assay represents a
significant improvement in the accurate
identification of PDV infected seals. The
assay can also be used to determine the
number of copies of virus relative to
infectivity based on 50% tissue culture
infectious dose (TCID50) calculations, al-
lowing quantitative estimation of virus load
in infected tissues.
MATERIALS AND METHODS
RNA extraction
Tissue samples of lung, liver, spleen, and
kidney stored at 280 C from harp seal (Phoca
groenlandica), harbor seal (Phoca vitulina
concolor), and gray seal (Halichoerus grypus)
were obtained from the University of New
England Marine Animal Rehabilitation and
Conservation Center in Biddeford, Maine,
USA (UNE MARC), for GAPDH sequencing.
Tissue samples from a PDV-negative harp
seal (MARC10-003Pg), a PDV-positive harbor
seal (MARC06-034Pv), a PDV-negative harbor
seal (MAR02-028Pv), and a suspect PDV-
positive gray seal (MARC06-019Hg) were
obtained for validation of the assay in tissue
samples. The initial PDV status of these seals
was based on clinical, gross, serologic, and
histopathologic findings reported to us by UNE
MARC. After tissue homogenization on dry ice
and further processed through a Qiashredder
column (Qiagen, Valencia, California, USA), we
extracted RNA using an RNeasy Plus Mini Kit
(Qiagen). The same RNA isolation procedure
was used to extract RNA from cultured PDV
USA 2006 for PDV H gene sequencing. The
RNA quantity (nanograms per microliter) was
determined using a Nanodrop 1000 Spectro-
photometer (Thermo Scientific, Wilmington,
Delaware, USA).
Virus culture
An isolate of PDV USA 2006 from a harbor
seal collected by UNE MARC that died of
morbillivirus infection, was kindly provided by
Ole Nielsen, Department of Fisheries and
Oceans Canada, as well as viruses used for
testing assay specificity. A transfected Vero cell
line (VeroDogSLAMtag) expressing canine
signaling lymphocyte activation molecules
(SLAMs) was provided by Y. Yanagi (Nielsen
et al. 2008) and used to quantify the TCID50
and viral titer for assay sensitivity. VeroDog-
SLAMtag cells were cultured and maintained
in medium consisting of Dulbecco’s Modified
Eagle Medium: Nutrient Mixture F-12
(DMEM/F12) (1:1) with L-glutamine and 4-
(2-hydroxyethyl)piperazine-1-ethanesulfonic
acid (Gibco, Grand Island, New York, USA),
10% Cosmic Calf Serum (HyClone, Logan,
Utah, USA), 200 mg/mL penicillin/streptomycin
(Gibco), and 0.25 mg/mL Fungizone (Gibco).
Viral isolation medium contained the above
with serum reduced to 2%, double the
concentration of penicillin/streptomycin
(400 mg/mL), and an additional 0.5 mg/mL
gentamicin (Gibco).
PDV H gene sequencing
The sequence of PDV USA 2006 was
unknown at the beginning of this project.
Therefore, the nucleotide sequence of the H
gene of the virus was determined by PCR
amplification and Sanger dideoxynucleotide
chain termination sequencing using the nucle-
otide sequence of the H gene of DK 2002 PDV
(GenBank FJ648456.1) to design forward and
reverse primers using Primer3 (Untergasser
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et al. 2012). The primers designated H-For and
H-Rev were produced by Applied Biosystems
(Life Technologies, Grand Island, New York,
USA) (Table 1).
The RNA extracted from PDV USA 2006
was reverse transcribed using a Superscript III
First Strand Synthesis System for RT-PCR
according to manufacturer’s instructions (In-
vitrogen, Carlsbad, California, USA). For
amplification of the cDNA, mix 1 was pre-
pared on ice containing 1 mL (10 mM) dNTP,
1 mL H-For Forward primer, 1 mL (10 mM)
H-Rev Reverse primer, 3 mL PDV cDNA, and
14 mL H2O and subsequently combined with
mix 2 containing 5 mL 53 buffer A, 5 mL 5%
buffer B, and 2 mL Elongase enzyme (Clon-
tech, Mountain View, California, USA) and
18 mL H2O. The PCR cycling conditions were
as described in Table 2a. The PCR products
were analyzed using a 1% agarose gel stained
with 5 mL Sybersafe DNA gel stain (Invitro-
gen) using 8 mL PCR product per lane with
2 mL loading dye and 1 kb and 500 kb Gelpilot
standards (Qiagen). The gel-isolated product
was purified using standard protocols in the
Qiaquick gel extraction kit (Qiagen). The
band-isolated PDV 2006 H gene PCR product
was cloned into a TOPO TA Cloning pCR2.1
plasmid vector (Invitrogen) followed with a
Qiaprep Spin Miniprep (Qiagen). Purified
DNA product was sequenced using the
vector’s M13 forward and reverse priming
sites (Genewiz, South Plainfield, New Jersey,
USA). The derived H gene sequence was
compared to the DK2002 and PDV 1988
sequences (GenBank accession FJ648456 and
AF479277) and to the published PDV 2006
USA H gene sequence (GenBank accession
HQ007902.1).
RNA quality/reference gene sequencing
A published 197-base pair (bp) GAPDH
sequence was chosen as an internal control for
RNA quality (Grant et al. 2009). The primer
sets were designated GRANT GAPDH-F and
GRANT GAPDH-R (Table 1). A 197-bp
GAPDH ds-DNA standard was created by
comparing multiple clones derived from am-
plification products of harp, harbor, and gray
seal RNA derived from multiple liver, lung,
and kidney samples from each species. The
Qiagen One-Step RT-PCR kit was used with
extracted RNA in 25 mL total reaction volumes
including 14 mL RNAse-free water, 5 mL 53
buffer, 1 mL (10 mM) dNTPs, 1.5 mL (10 nM)
forward primer, 1.5 mL (10 nM) reverse
primer, 2 mL Qiagen One-Step RT-PCR
enzyme mix, and 1 mL (5–20 ng) RNA. Cycling
conditions were as shown in Table 2b. The
expected 197-bp amplified product was recov-
ered by band isolation from agarose gel and
inserted into a plasmid vector (TOPO TA
Cloning pCR2.1 Invitrogen or pGEM-T Easy
Vector System; Promega, Madison, Wisconsin,
USA). Qiaprep Spin Miniprep (Qiagen) puri-
fied plasmid DNA was sequenced using the
vector’s M13 forward and reverse priming
sites (Genewiz). The derived GAPDH se-
quences were compared to published se-
quences in GenBank.
Ds-DNA Standards
Double-stranded DNA plasmid standards
(ds-DNA) were developed using a 116-bp
PDV USA 2006 H gene PCR product and a
197-bp GAPDH PCR product cloned into the
plasmid vectors used for sequencing. Copies of
the H gene fragment/mL plasmid were calcu-
lated using the following equation (Whelan
et al. 2003):
Copies~
6:02|1023 (copies=mol)|DNA amount (g)
DNA length (dp)|660 (g=mol=dp)
Tenfold dilutions of plasmids were made from
109 copies to 1 copy of plasmid per reaction
plate for standard curves.
The 116-bp PDV USA 2006 H gene se-
quence was amplified using primers for PDV
2002 H gene (Table 1). The PCR reaction
utilized 34.5 mL H20, 5 mL 103 buffer
(Clontech), 1 mL (10 mM) dNTP (Clontech),
0.5 mL polymerase 503 (Clontech), 2 mL PDV
116 forward primer (10 nM), 2 mL PDV 116
reverse primer (10 nM), and 3 mL cDNA. The
PCR cycling conditions for PDV USA 2006
cDNA using 116-bp H gene forward and 116-
bp H gene reverse primers were as described in
Table 2c. Amplified product was used to create
a ds-DNA plasmid by cloning the 116-bp
sequence from purified gel product into a
plasmid vector (TOPO TA Cloning pCR2.1,
Invitrogen). Qiaprep Spin Miniprep (Qiagen)
purified DNA product from this plasmid was
sequenced using the vector’s M13 reverse
priming site (Genewiz). The derived 116-bp
H gene sequence was compared to the PDV
DK2002 sequence, the PDV 1988 sequence,
and the PDV USA 2006 sequence (GenBank
accession HQ007902.1; Earle et al. 2011).
Development and optimization of primers and
probes for duplex RT-qPCR
For singleplex RT-qPCR, each primer and
probe set was tested independently using a
Quantitect Probe One Step RT-PCR reaction
(1)
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mix (Qiagen) on the Applied Biosystems 7500
Real Time Cycler. Targets were run in
singleplex in 96-well plates (Table 2d). A
minimum of eight log dilutions of each plasmid
standard were used as the positive control, as
well as a no template control and a reverse
transcription negative reaction per sample.
The reaction targeting PDV included
12.5 mL 23 Q buffer, 0.75 mL PDV 116
forward primer (300 nm), 0.75 mL PDV 116
reverse primer (300 nm), 0.5 mL of PDV probe
(50 nm), 0.25 mL Q mix, 5.25 mL RNAse-free
water, and 5 mL viral culture–derived PDV
RNA at 500 ng/mL. Standards for PDV in
singleplex were run from 100 to 109copies/mL.
A Taqman probe (FAM/TAM; Sigma-Aldrich,
St. Louis Missouri, USA) and primer set
previously designed for the PDV DK2002 H
gene were optimized and used to detect the
2006 PDV virus (Hammond et al. 2005).
The reaction targeting GAPDH included
12.5 mL 23 Q buffer, 0.5 mL Grant GAPDH-F
forward primer (200 nm), 0.5 mL Grant
GAPDH-R reverse primer (200 nm), 2.4 mL
of 1:40 GAPDH probe (240 nm), 0.25 mL Q
mix, 3.85 mL RNAse-free water, and 5 mL
RNA derived from seal tissues at 500 ng/mL.
Standards for GAPDH in singleplex were run
from 100 to 109copies/mL. The fluorescent
reporter dye was modified from VIC/TAM to
HEX/TAM (Sigma-Aldrich) (Grant et al.
2009).
The PDV 2006 and GAPDH primers and
probes were optimized for a duplex reaction
using Qiagen Quantifast Multiplex RT-PCR
+R in 96-well plates. Two initial reactions,
using 100 ng/mL PDV RNA derived from Vero
cell culture and separately using 100 ng/mL
seal-derived positive PDV tissue sample, were
first assayed and successfully confirmed the
TABLE 2. Cycling conditions for PCR, one-step reverse transcriptase (RT)-PCR, one-step RT-quantitative
(q)PCR, and duplex RT-qPCR.
Reactiona Cycling step Temperature (C) Time No. cycles
a. PCR PDV, H gene Initial denaturation 94 30 s 1
Denaturing 94 30 s 35
Annealing 57 30 s 35
Extension 68 2 min 30 s 1
Hold 4
b. PCR PDV, H gene
116-bp amplicon
Initial denaturation 95 2 min 1
Denaturing 95 30 s 35
Annealing 57 30 s 35
Extension 68 30 s 35
Final extension 68 5 min 1
Hold 4
c. One-step RT-PCR,
GAPDH
Reverse transcription 50 30 min 1
Activation 95 15 min 1
Denature 94 1 min 40
Annealing 60 45 s 40
Extension 72 1 min 40
Final extension 72 10 min 1
Hold 4
d. One-step RT-qPCR,
GAPDH, and PDV
Reverse transcription 50 30 min 1
Activation 95 15 min 1
Denature 94 15 s 40
Annealing/extension 60 1 min 40
Hold 4
e. Duplex RT-qPCR,
GAPDH, and PDV
Reverse transcription 50 20 min 1
Denature 95 5 min 40
Annealing 95 15 s 40
Extension 60 32 s 40
a PDV 5 phocine distemper virus; bp 5 base pair; GAPDH 5 glyceraldehyde-3-phosphate-dehydrogenase.
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detection of PDV and cell culture GAPDH, as
well as PDV and seal-derived GAPDH. For
the optimization of this assay, copies were
determined using a 100 ng/mL seal-derived
tissue RNA in duplicate. Controls were plated
as in singleplex. Each 20 mL sample reaction
contained: 10 mL Quantifast Master mix, 0.4 mL
ROX, 0.6 mL PDV forward primer (300 nm),
0.6 mL PDV reverse primer (300 nm), 0.4 mL
PDV probe (50 nm), 0.4 mL GAPDH forward
primer (200 nm), 0.4 mL GAPDH reverse
primer (200 nm), 1.92 mL GAPDH probe
(240 nm), 0.2 mL RT mix, and up to 5 mL of
RNA with sterile RNAse-free water. Concen-
trated seal tissue–derived RNA was first diluted
to 100 ng/mL with sterile PCR water. Standards
were run under the same conditions with
additional 3.08 mL water and 1 mL of each of
the PDV and GAPDH standard ds-DNA
plasmid in 10-fold serial dilutions from 100 to
109 (Table 2e.) Each fluorescent reporter signal
was measured against ROX added to the
reaction mixture above. The lowest level of
detection was the lowest dilution of the
standard to amplify. The baseline cycle thresh-
old value was set at the exponential increase
phase of the reaction for each standard.
Precision and efficiency of the singleplex and
duplex assay
Precision was calculated based on the R2 of
the standard curve. The PDV standards were
diluted from ds-DNA plasmid standards of
7.893109 copies/mL, and GAPDH standards
were diluted from plasmid standards of
8.893109 copies/mL. The PCR efficiencies
were calculated for each singleplex reaction
and for each channel in a duplex reaction.
Percentage efficiency was calculated by the
following formula (Rasmussen 2001):
E (PCR efficiency)~
10 1=slopeð Þ{1
 
|100% ð2Þ
Based on this equation, a PCR efficiency of a
100% is equal to a slope of 23.32.
Repeatability and reproducibility of the singleplex
and duplex assay
The coefficient of variability (CV; CV5stan-
dard deviation/mean) was used to calculate the
intra-assay variability. Three plasmid standards
(103, 105, 107) in eight replicates within a single
experiment for the singleplex assay and three
replicates for the duplex assay were measured.
Interassay variability CVs were measured from
three independent experiments using the same
three standards quantified in the intra-assay
variability measurements.
Specificity of the singleplex and duplex assay
Specificities of the singleplex and duplex
assay were performed using virus cultures. A
QiaAmp Viral RNA Mini extraction kit (Qia-
gen) was used to isolate RNA from viruses in
culture, including dolphin morbillivirus
(DMV), Steller sea lion reovirus (Palacios
et al. 2011), canine distemper virus (CDV)
Lederle strain, cetacean morbillivirus (CeMV)
isolated from Tursiops truncatus 2013, PDV
(Osterhauns 1988), and a seal picornavirus
(Kapoor et al. 2008). Viral RNA aliquots were
diluted 1:10 in sterile PCR water. Quantity of
RNA (ng/mL) was assessed using a Nanodrop
1000 Spectrophotometer (Thermo Scientific)
and 100 ng/mL of viral RNA was used in the
duplex and singleplex assay as described
earlier.
Relative infectious potential (TCID50) of PDV
USA 2006
The log10 50% tissue culture infectious dose
(TCID50) of PDV USA 2006 was calculated in
duplicate using 10-fold dilutions of virus
grown on SLAM-transfected Vero cells. Re-
sults were analyzed using the Spearmann-
Karber Titre calculator. The known TCID50
stock virus was made into 10-fold dilutions,
and RNA was then extracted using the Qiagen
Mini Viral RNA Isolation Kit. We used PDV
RNA in duplex RT-qPCR as described earlier.
The TCID50 equivalents were determined
from the copy numbers of ds-DNA standards
and therefore infectious PDV equivalents in
duplex reaction samples.
RESULTS
A subset of the resulting bands from
RT-PCR, singleplex, and duplex RT-
qPCR reactions were sequenced and
indicated specificity of the PDV H gene
(1824 bp), GAPDH (197 bp), and PDV
(116 bp) sequences. Comparison of the H
gene from three clones derived from first
passage of PDV 2006 USA indicates three
differences when compared with the pre-
viously sequenced 1952-bp PDV DK2002
(GenBank accession FJ648456.1) within
the 116-bp sequence detected by the
primers used for this assay (Fig. 1). Two
of these differences correspond to changes
previously described in the 1824-bp 2006
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sequence (GenBank accession HQ007902.1,
Earle et al. 2011) and one does not. In the
DK2002 sequence, at amino acid 200,
there is a substitution from P (proline) to
S (serine). This change is seen in our
sequence as well as in the recent 2006 PDV
virus sequence of the H gene correspond-
ing with a silent base pair substitution at
base 618, from nucleotides T to C. There is
also a silent mutation at base 683 with the
substitution of nucleotides A to T in both
2006 sequences when compared with the
DK2002 sequence. The differences be-
tween the two PDV 2006 USA sequences
lie at amino acid 218 at base 673 and results
in an amino acid substitution of N (aspar-
agine) to T (threonine). The probe used in
the development of this assay utilizes a
region conserved in the 1988, 2002, and
2006 isolates (Fig. 2) (Hammond et al.
2005).
The 197-bp GAPDH plasmid sequenc-
es derived from harbor, gray, and harp
seal tissues were compared to the previ-
ously published sequences and to GAPDH
sequences in GenBank (Grant et al. 2009).
At least three clones from three individuals
of each species, derived from lung, liver, or
kidney, were sequenced. Differences exist
within the probe region at positions 54 and
55 of the 197-bp sequence (Fig. 3). All
plasmids of the three species amplified
FIGURE 1. Sequence comparison of the phocine distemper virus (PDV) H gene from strains PDV USA
2006 sequenced in this study, PDV USA 2006 (GenBank accession HQ007902.1) and PDVDK2002 (GenBank
accession FJ648456.1) between nucleotide 597 and 712. Bold underlined nucleotides indicate differences
between sequences. Nucleic acids underlined with a zig-zag line indicate silent mutations. Below nucleotide
sequences are corresponding in amino acid sequences with changes underlined.
FIGURE 2. Alignment of phocine distemper virus (PDV) H gene sequences and targeted PDV H gene
plasmid and probe sequence used in this study. Sequences of PDV H gene are denoted by corresponding
GenBank accession numbers. Gray denotes areas of high consensus.
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using the GAPDH primer and probe set
despite the mismatches. The final GAPDH
plasmid standard was derived from harbor
seal lung tissue.
The previously published primer and
probe sequence used to amplify 2002 PDV
was used in a singleplex reaction to
compare with the duplex reaction. The
singleplex PDV real-time RT-PCR reac-
tion amplified PDV ds-plasmid DNA
standards, detecting 101 to109 copies with
an R2 of 0.9849, a slope of 22.88, and an
efficiency of 121.94%. The singleplex
GAPDH real-time RT-PCR reaction am-
plified ds-plasmid DNA in triplicate,
detecting 102 to108 copies with an R2 of
0.9815, a slope of 23.3223, and percent-
age efficiency of 99.984%.
Intra-assay variability for the singleplex
PDV assay for the three plasmid standards
(103, 105, 107) were 1.58%, 5.6%, 5.54%
and 4.85%, 7.05%, 4.44% for the single-
plex PDV and GAPDH assays, respective-
ly. Interassay variability for the same
standard dilutions for PDV were 5.89%,
7.86%, 9.91% for PDV and 5.36%, 1.89%,
6.81% for GAPDH.
The duplex real-time RT-PCR experi-
ments amplified PDV ds-plasmid DNA
from 100 to 109 copies with an R2 of 0.981,
a slope of 23.15897, and an efficiency of
107.28%. For the GAPDH ds-plasmid
DNA, the reaction amplified 100 to 109
copies with an R2 of 0.9865, a slope of
22.998, and an efficiency of 115.55%.
With three randomly selected replicates
of the duplex assay, the sensitivity of PDV
ds-plasmid DNA detection ranged from
102 to 109 copies with an R2 of 0.9781.
With the lower detection limit of 101 to
109 copies, the R2 diminished to 0.9682.
The sensitivity of the GAPDH detection in
the same three replicates ranged from 101
to 109 copies with an R2 of 0.9733. With
the lower detection limit of 100 to 109, the
R2 diminished to 0.9654.
Intra-assay CVs for the duplex assay for
the three plasmid standards (103, 105, 107)
were 2.73%, 1.38%, 3.69% and 2.24%,
1.33%, 3.14% for PDV and GAPDH,
respectively. Interassay CVs for three sep-
arate duplex assays for PDV were 4.75%,
16.84%, and 9.03%. The interassay CVs for
GAPDH were 2.4%, 5.47%, and 4.76%.
FIGURE 3. Sequence alignment of 197-base-pair glyceraldehyde-3-phosphate-dehydrogenase (GAPDH)
gene fragments from harbor seal (Phoca vitulina concolor [PV]), gray seal (Halichoerus grypus [HG]), and
harp seal (Phoca groenlandica [PG]). Sequences are aligned to the consensus sequence and GAPDH probe
used in the development of our assay. The plasmid probe used for the development of the assay was derived
from harbor seal lung tissue, represented as PV1.
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Both singleplex and duplex assays were
determined to be highly specific for PDV.
No detection occurred with DMV, CeMV,
CDV, Steller sea lion reovirus, or seal
picornavirus (data not shown).
PDV was calculated to have a TCID50
of 4.4 (log10TICD50/mL) equivalent to
25,118 infectious particles per mL with a
limit of detection and sensitivity of the
assay of 2.5 infectious particles, equivalent
to (mean6SD) 6.2564.3 copies of PDV
standard, to 25,118 infectious particles
with an equivalent of 479,6566419,797
copies PDV standard.
Using this assay on lung, liver, kidney, or
spleen tissues from seals of suspect or
known PDV status, PDV was detected in
kidney of the known positive harbor seal
(36,6413104 copies PDV standard/mL
RNA; 2.123106 copies GAPDH standard/
mL RNA). No PDV was detected in the
PDV-negative harbor seal in lung, liver,
spleen, or kidney (9.433105, 3.53108; 83,
9.53106 copies GAPDH standard/mL
RNA). No PDV was detected in the lung
of a PDV-negative harp seal (156.6 copies
GAPDH standard/mL RNA), and neither
PDV nor GAPDH was detected in the
spleen sample of the same individual,
resulting in the identification of a possible
false negative sample. No PDV was detect-
ed in the suspect positive gray seal in lung,
liver, spleen, or kidney (226, 8.933104,
2.953106, 3.153105 GAPDH/mL RNA).
DISCUSSION
Our assay assessed RNA sample quality
by measuring GAPDH, while simulta-
neously quantifying the target virus,
PDV. The use of an endogenous reference
gene to assess RNA quality has previously
been used in RT-PCR and RT-qPCR
studies (Inderwies et al. 2003; Hammond
et al. 2005; Persson et al. 2005; Grant et al.
2009; Takano et al. 2010; Brisco and
Morley 2012). The primer and probe set
we used has been shown to amplify 14
marine mammal species in singleplex RT-
qPCR (Grant et al. 2009). The duplex
assay offers benefits over using one- and
two-step RT-qPCR methods including the
reduction of template RNA necessary,
reduced chance for contamination over
two-step assays, and simultaneous assess-
ment of sample quality. Interpretation of
the results is facilitated in that the target
PDV gene is quantified in the same
reaction as the endogenous control gene.
Interpreting RT-qPCR results from
samples collected from stranded and often
decomposing carcasses is essential in
appropriately and unequivocally diagnos-
ing cases of infection, while avoiding false
negative findings. Despite that viral nu-
cleic acid may be protected from degra-
dation compared to host nucleic acid, a
means to assess interpretable samples as a
whole is necessary. Low RNA integrity can
be assessed through a multiplexed endog-
enous control gene. The use of an
endogenous locked nucleic acid LNA
primer and probe set in duplex, validated
by sequencing in an additional two species
of seal, will be useful in detecting false
negative PDV samples (Fleige and Pfaffl
2006; Hall et al. 2006).
Previously published serial dilution of
ds-DNA plasmid standards based on the
N gene of PDV using a singleplex RT-
qPCR recorded a sensitivity of 101 (Grant
2008). Using a ds-DNA plasmid standard,
detection was reported to be 10-fold more
sensitive for PDV over RNA standards
allowing for smaller amounts of detectable
RNA (Grant 2008). The singleplex assay
we used for the H gene amplicon is
equally as sensitive as those previously
reported. The duplex assay gave greater
sensitivity measuring one copy of PDV ds-
DNA standard. The GAPDH gene in
singleplex detected 102 copies while the
duplex assay was able to detect GAPDH to
101 with high precision. The variability
between assays was higher in duplex,
illustrating the importance of running
standards in each assay.
While the sensitivity of RT-qPCR is one
of the most useful benefits of the assay, it
does not provide biological relevance as to
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the infectious nature of the virus. Calcu-
lating the corresponding TCID50 of the
virus stock allows for more relevant quan-
tification of the viral load. The sensitivity of
the TCID50 assay not only relates to copies
of standard but to the number of infectious
particles detectable. Measuring PDV
through the duplex assay is therefore more
sensitive than quantifying virus through
viral titers. Furthermore, using the TCID50
equivalents gives the value of viral copy
number biological relevance.
Optimizing multiplex reactions offers
several challenges. Accurate quantification
is dependent on optimization of all com-
ponents of the reaction mixture to address
unequal rates of gene expression and RNA
quantity of the target genes (Persson et al.
2005). While the PDV and GAPDH
singleplex reactions had excellent preci-
sion, there was a slight loss of precision
and PCR efficiency in duplex. Efficiency
over 110% could suggest possible over-
amplification of the more abundant target
in the duplex reaction or a decrease in the
theoretical doubling of DNA in reaction
amplification at the far ends of the range
of detection (Bio-Rad Laboratories 2006;
Applied Biosystems 2007; Karlen et al.
2007). The kinetics related to the ampli-
fication of plasmid-derived RNA also
differ from tissue-derived RNA as well as
ds-DNA plasmid standards (Plaffl 2004).
In addition, the duplex reaction may favor
the LNA based probe and primer set.
Designing an LNA primer and probe for
the PDV H gene target could increase
efficiency without reducing the precision
(R2). A recent study targeting cetacean
morbilliviruses in singleplex RT-qPCR
using the Universal Probe Library could
similarly be used for developing an H gene
probe for PDV with higher efficiency in
multiplex (Rubio-Guerri et al. 2013).
Future development and optimization of
an exogenous RNA control would also aid
in a more robust multiplex assay.
Determining the identity and quantity
of infectious disease agents in stranded
marine mammals presents several unique
challenges. Degradation of RNA is an
inevitable limitation of diagnostic testing in
marine mammal mortality events and con-
tinues to be a challenge even with increas-
ingly sensitive molecular methods (Stroud
and Roffe 1979; Krafft et al. 1995; Saliki et
al. 2002). This assay helps address some of
these challenges by providing a useful
method to eliminate false negative samples
from a dataset due to degradation of RNA of
tissues and providing sensitive levels of
detection of PDV. The sensitivity of this
assay may also provide a useful method to
assess risk of exposure from subclinical
carriers of the virus, thereby enhancing the
ability to manage and prevent viral spread in
rehabilitation facilities. The duplex assay
may also be used to quantify viral load
during in-vitro infection experiments. This
assay can therefore provide a useful means
to investigate the pathogenicity and epide-
miology of PDV in field and laboratory
settings to improve our understanding of the
ecologic impact of PDV.
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